| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |